Multi-Site Eating Disorder Prevention Program for Type 1 Diabetes

Last updated: October 2, 2024
Sponsor: Oslo University Hospital
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Diabetes Mellitus, Type 1

Diabetes Mellitus Types I And Ii

Mood Disorders

Treatment

Diabetes Body Project

Educational Group

Clinical Study ID

NCT05399446
65953
  • Ages 14-35
  • All Genders

Study Summary

This study aims to test the effectiveness of an evidence-based eating-disorder prevention program specifically targeted for individuals with Type 1 Diabetes (T1D) compared to an educational control group. The Diabetes Body Project (DBP), is an adaptation of the Body Project which is the only eating disorder prevention program to have repeatedly produced effects when evaluated by independent researchers, produced stronger effects than credible alternative interventions, and affected objective outcomes. DBP has been adapted slightly for individuals with T1D who are at ultra-high risk for eating disorders. The study aims to test the effectiveness of the DBP of reducing body image concerns and reducing eating pathology and improving glycemic control.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. between the ages of 14-35

  2. diagnosis of Type 1 Diabetes of at least 1 year

  3. using insulin

  4. experiencing at least some level of body image concerns

Exclusion

Exclusion Criteria:

  1. not between the ages of 14-35

  2. does not have access to wifi (will need for the virtual groups)

  3. Type 1 Diabetes diagnosis of less than 1 year

  4. does not live in the same time zone of Stanford (helps in coordinating groups)

  5. hospitalized for eating disorder treatment in the past year

  6. had eating-disorder related Diabetic Ketoacidosis (DKA) in the past year

  7. not using insulin

  8. not experiencing any level of body image concerns

  9. Unwilling to be video-recorded if assigned to Diabetes Body Project

  10. restricted proficiency in language that groups will be conducted in (dependent onlocation), and pervasive developmental, cognitive, or psychiatric limitations thatcompromise participation in the intervention sessions and study.

Study Design

Total Participants: 280
Treatment Group(s): 2
Primary Treatment: Diabetes Body Project
Phase:
Study Start date:
January 01, 2023
Estimated Completion Date:
January 31, 2027

Connect with a study center

  • Amsterdam Medical University Center

    Amsterdam,
    Netherlands

    Site Not Available

  • Oslo University Hospital

    Oslo,
    Norway

    Site Not Available

  • Stanford University

    Stanford, California 94304
    United States

    Site Not Available

  • Joslin Diabetes Center

    Boston, Massachusetts 02215
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.